• Sildenafil 100 mg is an oral medication indicated for the treatment of erectile dysfunction in adult men. Its action helps improve blood flow to the penis during sexual stimulation, promoting the achievement and maintenance of an adequate erection for sexual activity.

  • Tadalafil 20 mg es un medicamento oral indicado para el tratamiento de la disfunción eréctil en hombres adultos. Su acción favorece el flujo sanguíneo hacia el pene durante la estimulación sexual, ayudando a obtener y mantener una erección adecuada. 

    El tadalafil también puede utilizarse, en una dosis diaria menor específicamente indicada por el médico, para aliviar síntomas urinarios asociados con la hiperplasia prostática benigna.

  • It is a peptide naturally produced by the body that plays an essential role in the regulation of the reproductive system. It acts by stimulating the release of GnRH, which promotes the production of LH and FSH hormones, related to ovarian and testicular function, ovulation, and the production of sex hormones.

    Currently, its potential in reproductive medicine, hormonal disorders, fertility, and sexual function is being investigated. Because its therapeutic applications are still under clinical evaluation.

  • Also known as bremelanotide, it is a synthetic peptide administered subcutaneously that acts on the melanocortin receptors of the central nervous system. Unlike sildenafil and tadalafil, its action is not primarily based on increasing genital blood flow, but rather on stimulating brain pathways related to desire and sexual response.

    Bremelanotide is approved in the United States for the treatment of acquired and generalized hypoactive sexual desire disorder in premenopausal women. It is not approved to enhance sexual performance or to treat male erectile dysfunction, so its marketing must comply with the health regulations of each country.

Sexual Health

  • It is an injectable medication administered subcutaneously once a week that acts simultaneously on GIP and GLP-1 receptors. According to the authorization of each market, it is used to improve glucose control in adults with type 2 diabetes and for weight management in people with obesity or overweight associated with certain health conditions.

    Its mechanism helps regulate appetite, reduce food intake, and improve the body's response to glucose. It should be used under medical prescription and supervision, as a complement to a balanced diet and physical activity.

  • It is a weekly subcutaneous injectable medication that acts simultaneously on the GIP, GLP-1, and glucagon receptors. It is currently being investigated for the treatment of obesity, overweight, and type 2 diabetes, with promising clinical results in body weight reduction and metabolic control.

    Retatrutide continues to be an investigational molecule and is not yet approved for commercialization. Its safety, efficacy, and dosage are still being evaluated in phase 3 clinical trials.

  • COMPOSITION: EACH UNCOATED TABLET CONTAINS: SODIUM LIOTHYRONINE 25 MCG

    LIOTIRONINA is used to treat hypothyroidism (underactive thyroid). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Liothyronine is a synthetic form of thyroid hormone. Low levels of thyroid hormone can occur naturally or when the thyroid gland is damaged by radiation/medications or surgically removed. Having enough thyroid hormone helps you stay healthy. For children, having enough thyroid hormone helps them grow and learn normally.

    This medication is also used to treat other types of thyroid problems (such as certain types of goiters, thyroid cancer). It can also be used to detect certain types of thyroid diseases.

    This medication should not be used to treat infertility unless it is caused by low levels of thyroid hormones.

    PRESENTATION: 2 Blister Packs of 25 Tablets each in a Single Carton with insert.

Metabolic Health

  • It is a copper peptide naturally present in the body and studied for its involvement in tissue repair processes, extracellular matrix remodeling, and the production of structural components of the skin. Its potential application in esthetic medicine is related to supporting skin regeneration, wound healing, and improving the appearance of the skin.

  • It is a copper-bound tripeptide that is mainly investigated for its possible involvement in hair follicle growth and maintenance. In laboratory studies and in human hair follicles cultured ex vivo, it showed the ability to stimulate hair elongation and the proliferation of dermal papilla cells.

  • It is an experimental peptide formulation that combines BPC-157, TB-500, KPV, and GHK-Cu. Its components are being investigated for their possible involvement in tissue repair processes, cellular regeneration, extracellular matrix remodeling, and regulation of inflammatory pathways.

Esthetic Medicine

1
3